Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2025-2037
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2025
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2025
Characteristic | Total | Colorectal, n = 101 | Non-colorectal digestive cancer, n = 102 | P value | λ | |||
n | % | n | % | n | % | |||
Sex | 0.622 | 0.026 | ||||||
Men | 115 | 56.7 | 60 | 59.4 | 55 | 53.9 | ||
Women | 88 | 43.3 | 41 | 40.6 | 47 | 46.1 | ||
Age | 0.028 | 0.081 | ||||||
≤ 65 yr | 85 | 41.9 | 50 | 49.5 | 35 | 34.3 | ||
> 65 yr | 118 | 59.1 | 51 | 50.5 | 67 | 65.7 | ||
Number of Elixhauser comorbidities (%) | 0.344 | 0.033 | ||||||
≤ 4 | 81 | 39.9 | 37 | 36.6 | 44 | 43.1 | ||
> 4 | 122 | 60.1 | 64 | 63.4 | 58 | 56.9 | ||
ECOG | 0.029 | 0.086 | ||||||
0 | 56 | 27.6 | 35 | 34.7 | 21 | 20.6 | ||
1 | 138 | 68.0 | 62 | 61.4 | 76 | 74.5 | ||
2 | 9 | 4.4 | 4 | 4.0 | 5 | 4.9 | ||
Marital status | 0.883 | 0.001 | ||||||
Married/partnered | 167 | 86.6 | 87 | 86.2 | 92 | 87.0 | ||
Not partnered | 36 | 13.4 | 24 | 13.8 | 24 | 13.0 | ||
Children | 0.370 | 0.029 | ||||||
Do not have children | 35 | 17.2 | 15 | 14.9 | 20 | 19.6 | ||
Have children | 168 | 82.8 | 86 | 85.1 | 82 | 81.4 | ||
Educational level | 0.521 | 0.010 | ||||||
Primary | 112 | 55.2 | 58 | 57.4 | 54 | 52.9 | ||
High school or higher | 91 | 44.8 | 43 | 42.6 | 48 | 47.1 | ||
Histology | 0.001 | 0.129 | ||||||
Adenocarcinoma | 180 | 88.7 | 98 | 97.0 | 82 | 80.4 | ||
Others | 23 | 11.3 | 3 | 3.0 | 20 | 19.6 | ||
Metastasis | 0.001 | 0.218 | ||||||
Locally advanced | 32 | 15.8 | 1 | 1.0 | 31 | 30.4 | ||
Metastatic disease | 171 | 84.2 | 100 | 99.0 | 71 | 69.6 | ||
Biomarker | 0.001 | 0.196 | ||||||
No | 161 | 79.3 | 66 | 65.3 | 95 | 93.1 | ||
Yes | 42 | 20.7 | 35 | 34.7 | 7 | 6.9 | ||
Estimated survival | 0.001 | 0.776 | ||||||
< 18 mo | 108 | 53.2 | 14 | 13.9 | 94 | 92.2 | ||
≥ 18 mo | 95 | 4.8 | 87 | 86.1 | 8 | 7.8 | ||
Treatment modality | 0.001 | 0.339 | ||||||
Chemotherapy | 139 | 68.5 | 45 | 44.6 | 94 | 92.2 | ||
Combined | 64 | 31.5 | 56 | 54.4 | 8 | 7.8 |
Scales | Colorectal cancer, n = 101 | Non-colorectal digestive cancer, n = 102 | ANOVA results, F | ||||
Men, mean (SD) | Women, mean (SD) | Men, mean (SD) | Women, mean (SD) | Tumor × sex | Tumor | Sex | |
Psych. distress (BSI)1 | |||||||
Somatization | 62.0 (6.3) | 64.1 (8.0) | 63.9 (6.7) | 66.3 (8.1) | 0.021 | 3.963 | 5.044 |
Depression | 60.3 (6.6) | 65.0 (6.6) | 60.1 (5.5) | 62.9 (7.5) | 0.923 | 1.423 | 15.747 |
Anxiety | 61.9 (7.8) | 65.8 (8.3) | 61.9 (6.8) | 66.0 (8.3) | 0.030 | 0.011 | 12.818 |
Quality of life (EORTC-QLQ-C30)2 | |||||||
Functional scale | 79.6 (17.4) | 62.3 (23.0) | 70.8 (22.6) | 60.8 (24.0) | 1.427 | 2.781 | 19.697 |
Symptom scale | 24.4 (22.9) | 29.8 (19.4) | 28.6 (17.8) | 40.0 (22.1) | 1.044 | 6.067 | 8.154 |
Health status scale | 67.6 (22.6) | 53.7 (27.9) | 51.9 (23.5) | 55.1 (32.8) | 5.185 | 3.547 | 2.059 |
Coping with cancer (M-MAC)2 | |||||||
Helplessness | 24.0 (22.9) | 25.0 (21.9) | 25.9 (22.8) | 28.6 (25.6) | 0.069 | 0.696 | 0.288 |
Anxious preoccupation | 46.2 (24.4) | 51.4 (18.8) | 43.8 (19.0) | 54.4 (23.6) | 0.800 | 0.008 | 6.722 |
Positive attitude | 83.4 (16.5) | 76.8 (18.1) | 79.2 (15.8) | 74.9 (22.9) | 0.186 | 1.364 | 4.389 |
Cognitive avoidance | 66.6 (27.3) | 60.6 (21.6) | 64.3 (24.5) | 60.2 (27.1) | 0.036 | 0.192 | 1.758 |
- Citation: Pacheco-Barcia V, Gomez D, Obispo B, Mihic Gongora L, Hernandez San Gil R, Cruz-Castellanos P, Gil-Raga M, Villalba V, Ghanem I, Jimenez-Fonseca P, Calderon C. Role of sex on psychological distress, quality of life, and coping of patients with advanced colorectal and non-colorectal cancer. World J Gastrointest Oncol 2022; 14(10): 2025-2037
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/2025.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.2025